Morgan Stanley Maintains Equal-Weight on Adient, Lowers Price Target to $21
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Morgan Stanley analyst Andrew Percoco maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $22 to $21.
Morgan Stanley analyst Andrew Percoco maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $22 to $21.